Clinical Trial 31254

Ocala, FL 34471


Study Summary:

The study is for individuals with Alzheimer's Disease or mild cognitive impairment due to Alzheimer's Disease. The study lasts 18 months with an optional 24 month long-term extension. The study includes the completion of MRI and PET scan imaging.


Qualified Participants Must:

• Be between 50 and 85 years of age
• Have experienced memory decline for at least one year
• Suspect memory decline may be due to Alzheimer's Disease or have been diagnosed with Alzheimer's Disease


Qualified Participants May Receive:

Study-related medical care and study medication; reimbursement for time and travel will be provided


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.